Nuclear Medicine Equipment Market by Product (Imaging: PET, SPECT, Gamma; GM Counter, Dose Calibrator), Software (Image Management, PACS, Treatment, Analytic, Workflow), Therapy (Onco, Cardio, Neuro, Ortho), End User & Region - Global Forecasts to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders

2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Research
2.1.2.1 Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Breakdown of Primary Interviews
2.1.2.4 Insights from Primary Experts
2.2 Research Methodology
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Market Share Estimation
2.6 Research Assumptions
2.7 Research Limitations
2.8 Risk Assessment

4.1 Overview of Nuclear Medicine Equipment Market
4.2 Asia-Pacific: Nuclear Medicine Equipment Market, by Therapeutic Area
4.3 Geographic Snapshot of Nuclear Medicine Equipment Market
4.4 Nuclear Medicine Equipment Market: Regional Mix
4.5 Nuclear Medicine Equipment Market: Developed Vs. Emerging Markets

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Expansion of Theranostics
5.2.1.2 Technological Advancements in Hybrid Imaging Modalities
5.2.1.3 Favorable Government Support and Expanding Healthcare Infrastructure
5.2.1.4 Advancements in Radiotracers and Radiopharmaceuticals
5.2.1.5 Integration of AI into Nuclear Medicine Equipment
5.2.2 Restraints
5.2.2.1 Capital-Intensive Nature of Equipment
5.2.2.2 Short Half-Life of Radiopharmaceuticals
5.2.2.3 High Maintenance and Operational Costs
5.2.2.4 Shortage of Trained Personnel
5.2.3 Opportunities
5.2.3.1 Growing Preference for Personalized and Precision Medicine
5.2.3.2 Telemedicine and Cloud-Native Platforms & Mobile/Remote Imaging Capabilities
5.2.4 Challenges
5.2.4.1 Global Isotope Supply Chain Instability
5.2.4.2 Cybersecurity and Data Privacy Issues in Imaging It
5.3 Trends/Disruptions Impacting Customer Business
5.4 Industry Trends
5.4.1 Shift Toward Hybrid and Multi-Modality Imaging Systems
5.4.2 Advancements in Detector Technologies and Image Quality
5.4.3 Growing Demand for Compact and Versatile Systems
5.4.4 Integration of Artificial Intelligence and Automation
5.4.5 Connectivity and Cloud-Enabled Workflows
5.5 Pricing Analysis
5.5.1 Introduction
5.5.2 Indicative Price of Nuclear Medicine Equipment, by Key Player
5.5.3 Indicative Price of Nuclear Medicine Equipment, by Region
5.5.4 Average Selling Price of Nuclear Cardiology Reporting Software
5.5.5 Pricing Models
5.6 Value Chain Analysis
5.7 Ecosystem Analysis
5.8 Investment and Funding Scenario
5.9 Technology Analysis
5.9.1 Key Technologies
5.9.1.1 Hybrid Imaging Systems
5.9.1.2 Digital Detection Technology
5.9.1.3 Artificial Intelligence (AI) and Advanced Image Reconstruction Techniques
5.9.1.4 Time-Of-Flight (Tof) Technology
5.9.1.5 Solid-State Detector Technology
5.9.2 Complementary Technologies
5.9.2.1 Radiopharmaceutical Development and Theranostics
5.9.2.2 Advanced Computing and Big Data Analytics
5.9.2.3 Robotics and Automated Dose Dispensing Systems
5.9.3 Adjacent Technologies
5.9.3.1 Magnetic Resonance Imaging (Mri) Integration
5.9.3.2 Computed Tomography (Ct) Advancements
5.10 Patent Analysis
5.11 Trade Analysis
5.11.1 Import Data for Hs Code 901814
5.11.2 Export Data for Hs Code 901814
5.12 Key Conferences and Events, 2025-2026
5.13 Case Study Analysis
5.13.1 Precision in Nuclear Medicine with National Standard Traceability
5.13.2 Multi-Modality Image Fusion for Improved Diagnostics
5.13.3 Remote Consultation with Cloud-Based Nuclear Medicine Analysis
5.14 Tariff and Regulatory Landscape
5.14.1 Tariff Data for Hs Code 901814
5.14.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.14.3 Regulatory Analysis
5.15 Porter's Five Forces Analysis
5.15.1 Bargaining Power of Suppliers
5.15.2 Bargaining Power of Buyers
5.15.3 Threat of New Entrants
5.15.4 Threat of Substitutes
5.15.5 Intensity of Competitive Rivalry
5.16 Key Stakeholders and Buying Criteria
5.16.1 Key Stakeholders in Buying Process
5.16.2 Buying Criteria
5.17 End-User Analysis
5.17.1 Unmet Needs
5.17.2 End-User Expectations
5.18 Business Model
5.18.1 Direct Equipment Sales Model
5.18.2 Service and Maintenance Contracts
5.18.3 Pay-Per-Scan (Or Pay-Per-Use) Model
5.18.4 Equipment Leasing and Financing Solutions
5.18.5 Integrated Solutions and Managed Services
5.18.6 Software and Data Analytics Subscription
5.19 Impact of AI/Gen AI
5.19.1 Introduction
5.19.2 Market Potential of AI/Gen AI
5.19.3 Case Studies Related to AI/Gen AI Implementation
5.19.3.1 AI-Based Low-Dose Pet Image Reconstruction
5.19.3.2 Dose-Aware Diffusion Models for 3D Low-Dose Pet
5.19.4 Impact of AI/Gen AI on Interconnected and Adjacent Ecosystems
5.19.4.1 Medical Image Analysis Software
5.19.4.2 Radiology Information Systems
5.19.4.3 Clinical Decision Support Systems
5.19.5 User Readiness and Impact Assessment
5.19.5.1 User Readiness
5.19.5.1.1 User A: Hospitals
5.19.5.1.2 User B: Diagnostic Imaging Centers
5.19.5.2 Impact Assessment
5.19.5.2.1 User A: Hospitals
5.19.5.2.2 User B: Diagnostic Imaging Centers
5.20 Impact of 2025 Us Tariff - Overview
5.20.1 Introduction
5.20.2 Key Tariff Rates
5.20.3 Price Impact Analysis
5.20.3.1 Capital Equipment (Cyclotrons, Pet/Spect Systems)
5.20.3.2 Gamma Cameras
5.20.3.3 Key Materials: Semiconductors, Detectors, Shielding
5.20.3.4 Service Parts, Maintenance, and Global Supply Chains
5.20.4 Impact on Country/Region
5.20.4.1 Us
5.20.4.2 Europe
5.20.4.3 Asia-Pacific
5.20.5 Impact on End-Use Industries
5.20.5.1 Hospitals
5.20.5.2 Diagnostic Imaging Centers
5.20.5.3 Cancer Treatment Centers
5.20.5.4 Other End-Users
5.20.6 Conclusion

6.1 Introduction
6.2 Imaging Modalities
6.2.1 Pet
6.2.1.1 Standalone Pet
6.2.1.1.1 Increasing Demand for Cost-Efficient, High-Throughput Oncological Imaging to Boost Market
6.2.1.2 Hybrid Pet
6.2.1.2.1 Ability to Provide Functional and Anatomical Information in Single Scan to Aid Growth
6.2.2 Spect
6.2.2.1 Standalone Spect
6.2.2.1.1 Wide Use in Thyroid Studies, Renal Scans, and Bone Imaging to Encourage Growth
6.2.2.2 Hybrid Spect
6.2.2.2.1 Need for Improved Diagnostic Accuracy and Clinical Confidence to Propel Market
6.2.3 Gamma/Scintillation Cameras
6.2.3.1 Clinical Versatility and Lower Cost to Expedite Growth
6.3 Non-Imaging Modalities
6.3.1 Gm Counters
6.3.1.1 Ease of Use, Portability, and Critical Role in Maintaining Workplace Safety to Spur Growth
6.3.2 Dose Calibrators
6.3.2.1 Increasing Development in Digital Interfaces, Automatic Isotope Recognition, and Real-Time Data Logging to Bolster Growth
6.3.3 Probe Counting Systems
6.3.3.1 Technological Advancements in Probe Counting Systems to Contribute to Growth
6.3.4 Gamma Well Counters
6.3.4.1 Growing Use of Gamma Well Counters in Laboratory-Based Applications to Propel Market
6.3.5 Other Non-Imaging Modalities

7.1 Introduction
7.2 Oncology
7.2.1 Improvements in Imaging Accuracy and Treatment Planning to Stimulate Growth
7.3 Neurology
7.3.1 Escalating Global Burden of Neurodegenerative Disorders and Other Neurological Conditions to Aid Growth
7.4 Cardiology
7.4.1 Persistent Global Burden of Cardiovascular Diseases to Facilitate Growth
7.5 Orthopedics
7.5.1 Growing Prevalence of Degenerative Joint Diseases, Sports Injuries, and Osteoporosis to Boost Market
7.6 Thyroid
7.6.1 Global Prevalence of Hyper- and Hypothyroidism and Thyroid Cancer to Augment Growth
7.7 Other Therapeutic Areas

8.1 Introduction
8.2 2D
8.2.1 Wide Availability, Ease of Integration, and Established Presence in Clinical Workflow to Aid Growth
8.3 3D
8.3.1 Growing Reliance on Advanced Imaging Technologies to Fuel Market

9.1 Introduction
9.2 Hospitals
9.2.1 Continuous Technological Advancements to Foster Growth
9.3 Diagnostic Imaging Centers
9.3.1 Growing Demand for Early and Precise Diagnosis to Drive Market
9.4 Cancer Treatment Centers
9.4.1 Escalating Global Incidence of Cancer to Promote Growth
9.5 Other End-Users

10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook for North America
10.2.2 Us
10.2.2.1 Advancements in Pet and Spect Equipment for Personalized Care to Aid Growth
10.2.3 Canada
10.2.3.1 Increasing Adoption of Advanced Imaging Technologies to Support Growth
10.3 Europe
10.3.1 Macroeconomic Outlook for Europe
10.3.2 Germany
10.3.2.1 Increasing Adoption of Hybrid Imaging Systems to Spur Growth
10.3.3 Uk
10.3.3.1 Favorable Clinical Guidelines Supporting Wider Use of Pet-Ct to Fuel Market
10.3.4 France
10.3.4.1 Shift to Hybrid Imaging to Accelerate Growth
10.3.5 Italy
10.3.5.1 Robust Network of Scanners to Facilitate Growth
10.3.6 Spain
10.3.6.1 Growing Integration of Cutting-Edge Technologies into Clinical Practice to Propel Market
10.3.7 Sweden
10.3.7.1 Rapid Shift Toward Pet Procedures to Accelerate Growth
10.3.8 Rest of Europe
10.4 Asia-Pacific
10.4.1 Macroeconomic Outlook for Asia-Pacific
10.4.2 Japan
10.4.2.1 Ongoing Innovations in Equipment and Growing Reliance on Nuclear Imaging for Accurate Detection to Drive Market
10.4.3 China
10.4.3.1 Rapid Investments in Medical Infrastructure and Technological Advancements in Image Analysis to Spur Growth
10.4.4 India
10.4.4.1 Substantial Cancer and Cardiovascular Disease Burden to Encourage Growth
10.4.5 South Korea
10.4.5.1 Universal Health Coverage to Bolster Growth
10.4.6 Australia
10.4.6.1 Strong Diagnostic Imaging Network and Widespread Adoption of Hybrid Imaging Technologies to Contribute to Growth
10.4.7 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Macroeconomic Outlook for Middle East & Africa
10.5.2 Gcc Countries
10.5.2.1 Growing Healthcare Needs and Favorable Government Support to Boost Market
10.5.3 Rest of Middle East & Africa
10.6 Latin America
10.6.1 Macroeconomic Outlook for Latin America
10.6.2 Brazil
10.6.2.1 Healthcare Modernization Efforts to Accelerate Growth
10.6.3 Mexico
10.6.3.1 Expanding Healthcare Infrastructure to Bolster Growth
10.6.4 Rest of Latin America

11.1 Overview
11.2 Key Player Strategies
11.2.1 Overview of Strategies Adopted by Key Players in Nuclear Medicine Equipment Market
11.3 Revenue Analysis, 2020-2024
11.4 Market Share Analysis, 2024
11.4.1 Positron Emission Tomography (Pet) Equipment
11.4.2 Single-Photon Emission Computed Tomography (Spect) Equipment
11.5 Market Ranking Analysis
11.6 Brand/Product Comparison
11.7 Company Valuation and Financial Metrics
11.8 Company Evaluation Matrix: Key Players, 2024
11.8.1 Stars
11.8.2 Emerging Leaders
11.8.3 Pervasive Players
11.8.4 Participants
11.8.5 Company Footprint: Key Players, 2024
11.8.5.1 Company Footprint
11.8.5.2 Region Footprint
11.8.5.3 System Type Footprint
11.8.5.4 Therapeutic Area Footprint
11.8.5.5 Dimension Footprint
11.8.5.6 End-User Footprint
11.9 Company Evaluation Matrix: Startups/Smes, 2024
11.9.1 Progressive Companies
11.9.2 Responsive Companies
11.9.3 Dynamic Companies
11.9.4 Starting Blocks
11.9.5 Competitive Benchmarking: Startups/Smes, 2024
11.9.5.1 Detailed List of Key Startups/Smes
11.9.5.2 Competitive Benchmarking of Startups/Smes
11.10 Competitive Scenario
11.10.1 Product Launches and Approvals
11.10.2 Deals
11.10.3 Expansions
11.10.4 Other Developments

12.1 Key Players
12.1.1 Ge Healthcare
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Product Launches and Approvals
12.1.1.3.2 Deals
12.1.1.3.3 Expansions
12.1.1.4 Analyst's View
12.1.1.4.1 Right to Win
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses and Competitive Threats
12.1.2 Siemens Healthineers Ag
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Product Launches and Approvals
12.1.2.3.2 Deals
12.1.2.4 Analyst's View
12.1.2.4.1 Right to Win
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses and Competitive Threats
12.1.3 Koninklijke Philips N.V.
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Launches and Approvals
12.1.3.3.2 Deals
12.1.3.4 Analyst's View
12.1.3.4.1 Right to Win
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses and Competitive Threats
12.1.4 Mirion Technologies, Inc.
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Launches and Approvals
12.1.4.3.2 Deals
12.1.4.4 Analyst's View
12.1.4.4.1 Right to Win
12.1.4.4.2 Strategic Choices
12.1.4.4.3 Weaknesses and Competitive Threats
12.1.5 Canon Medical Systems Corporation
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Deals
12.1.5.4 Analyst's View
12.1.5.4.1 Right to Win
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses and Competitive Threats
12.1.6 Hermes Medical Solutions
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches and Approvals
12.1.6.3.2 Deals
12.1.6.3.3 Other Developments
12.1.7 Dosisoft Sa
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Product Launches and Approvals
12.1.7.3.2 Deals
12.1.8 Segami Corporation
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.9 Winkgen Medical Systems GmbH & Co. Kg
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Product Launches and Approvals
12.1.9.3.2 Deals
12.1.10 Comecer S.P.A.
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.10.3 Recent Developments
12.1.10.3.1 Product Launches and Approvals
12.1.10.3.2 Deals
12.1.10.3.3 Expansions
12.1.11 Syntermed Inc.
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.11.3 Recent Developments
12.1.11.3.1 Deals
12.1.12 Ultraspect Inc.
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.13 Lablogic Systems Ltd.
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Product Launches and Approvals
12.1.13.3.2 Deals
12.1.13.3.3 Expansions
12.1.14 Mediso Ltd.
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.14.3 Recent Developments
12.1.14.3.1 Product Launches and Approvals
12.1.15 Catalyst Medtech
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.1.15.3 Recent Developments
12.1.15.3.1 Deals
12.1.15.3.2 Other Developments
12.1.16 Lemer Pax
12.1.16.1 Business Overview
12.1.16.2 Products Offered
12.1.16.3 Recent Developments
12.1.16.3.1 Product Launches and Approvals
12.1.16.3.2 Deals
12.1.17 Spectrum Dynamics Medical
12.1.17.1 Business Overview
12.1.17.2 Products Offered
12.1.17.3 Recent Developments
12.1.17.3.1 Product Launches and Approvals
12.1.17.3.2 Deals
12.1.18 Neusoft Medical Systems Co. Ltd.
12.1.18.1 Business Overview
12.1.18.2 Recent Developments
12.1.18.2.1 Product Launches and Approvals
12.1.18.2.2 Deals
12.1.19 Brainlab Se
12.1.19.1 Business Overview
12.1.19.2 Products Offered
12.1.19.3 Recent Developments
12.1.19.3.1 Product Launches and Approvals
12.1.19.3.2 Deals
12.1.20 Mirada Medical
12.1.20.1 Business Overview
12.1.20.2 Products Offered
12.1.20.3 Recent Developments
12.1.20.3.1 Product Launches and Approvals
12.1.20.3.2 Deals
12.2 Other Players
12.2.1 Trasis
12.2.2 Sofie
12.2.3 Itm Isotope Technologies Munich Se
12.2.4 Positrigo Ag
12.2.5 Paire

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Nuclear Medicine Equipment Market: Inclusions and Exclusions
Table 2 Exchange Rates Utilized for Conversion to Usd, 2021-2024
Table 3 Nuclear Medicine Equipment Market: Research Assumptions
Table 4 Nuclear Medicine Equipment Market: Risk Assessment
Table 5 Nuclear Medicine Equipment Market: Impact Analysis of Market Dynamics
Table 6 Indicative Price of Nuclear Medicine Equipment, by Key Player, 2024 (USD)
Table 7 Indicative Price of Nuclear Medicine Equipment, by Region, 2024 (USD)
Table 8 Average Selling Price of Nuclear Cardiology Reporting Software, 2024 (USD)
Table 9 Nuclear Medicine Equipment Market: Role of Companies in Ecosystem
Table 10 Jurisdiction Analysis of Top Applicant Countries for Nuclear Medicine Equipment Market, 2025
Table 11 Import Data for Hs Code 901814, by Country, 2020-2024 (USD Thousand)
Table 12 Exports Data for Hs Code 901814, by Country, 2020-2024 (USD Thousand)
Table 13 Nuclear Medicine Equipment Market: Key Conferences and Events, 2025-2026
Table 14 Tariff Data for Hs Code 901814
Table 15 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Regulatory Standards in Nuclear Medicine
Table 19 Regulatory Requirements in North America
Table 20 Regulatory Requirements in Europe
Table 21 Regulatory Requirements in Asia-Pacific
Table 22 Regulatory Requirements in Latin America
Table 23 Regulatory Requirements in Middle East & Africa
Table 24 Nuclear Medicine Equipment Market: Porter's Five Forces Analysis
Table 25 Influence of Stakeholders on Buying Process, by End-User (%)
Table 26 Key Buying Criteria for End-Users
Table 27 Unmet Needs in Nuclear Medicine Equipment Market
Table 28 End-User Expectations in Nuclear Medicine Equipment Market
Table 29 Us Adjusted Reciprocal Tariff Rates
Table 30 Nuclear Medicine Equipment, by System Type, 2023-2030 (USD Million)
Table 31 Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 32 Nuclear Medicine Equipment Market for Imaging Modalities, by Region, 2023-2030 (USD Million)
Table 33 Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (Units)
Table 34 Pet Equipment Offered by Major Players
Table 35 Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 36 Nuclear Medicine Equipment Market for Pet, by Region, 2023-2030 (USD Million)
Table 37 Nuclear Medicine Equipment Market for Standalone Pet, by Region, 2023-2030 (USD Million)
Table 38 Nuclear Medicine Equipment Market for Hybrid Pet, by Region, 2023-2030 (USD Million)
Table 39 Spect Equipment Offered by Major Players
Table 40 Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 41 Nuclear Medicine Equipment Market for Spect, by Region, 2023-2030 (USD Million)
Table 42 Nuclear Medicine Equipment Market for Standalone Spect, by Region, 2023-2030 (USD Million)
Table 43 Nuclear Medicine Equipment Market for Hybrid Spect, by Region, 2023-2030 (USD Million)
Table 44 Gamma/Scintillation Cameras Offered by Major Players
Table 45 Nuclear Medicine Equipment Market for Gamma/Scintillation Cameras, by Region, 2023-2030 (USD Million)
Table 46 Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 47 Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Region, 2023-2030 (USD Million)
Table 48 Gm Counters Offered by Major Players
Table 49 Nuclear Medicine Equipment Market for Gm Counters, by Region, 2023-2030 (USD Million)
Table 50 Dose Calibrators Offered by Major Players
Table 51 Nuclear Medicine Equipment Market for Dose Calibrators, by Region, 2023-2030 (USD Million)
Table 52 Probe Counting Systems Offered by Major Players
Table 53 Nuclear Medicine Equipment Market for Probe Counting Systems, by Region, 2023-2030 (USD Million)
Table 54 Gamma Well Counters Offered by Major Players
Table 55 Nuclear Medicine Equipment Market for Gamma Well Counters, by Region, 2023-2030 (USD Million)
Table 56 Nuclear Medicine Equipment Market for Other Non-Imaging Modalities, by Region, 2023-2030 (USD Million)
Table 57 Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 58 Nuclear Medicine Equipment for Oncology Offered by Major Players
Table 59 Nuclear Medicine Equipment Market for Oncology, by Region, 2023-2030 (USD Million)
Table 60 Nuclear Medicine Equipment for Neurology Offered by Major Players
Table 61 Nuclear Medicine Equipment Market for Neurology, by Region, 2023-2030 (USD Million)
Table 62 Nuclear Medicine Equipment for Cardiology Offered by Major Players
Table 63 Nuclear Medicine Equipment Market for Cardiology, by Region, 2023-2030 (USD Million)
Table 64 Nuclear Medicine Equipment for Orthopedics Offered by Major Players
Table 65 Nuclear Medicine Equipment Market for Orthopedics, by Region, 2023-2030 (USD Million)
Table 66 Nuclear Medicine Equipment for Thyroid Offered by Major Players
Table 67 Nuclear Medicine Equipment Market for Thyroid, by Region, 2023-2030 (USD Million)
Table 68 Nuclear Medicine Equipment Market for Other Therapeutic Areas, by Region, 2023-2030 (USD Million)
Table 69 Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 70 Nuclear Medicine 2D Equipment Offered by Major Players
Table 71 Nuclear Medicine 2D Equipment Market, by Region, 2023-2030 (USD Million)
Table 72 Nuclear Medicine 3D Equipment Offered by Major Players
Table 73 Nuclear Medicine 3D Equipment Market, by Region, 2023-2030 (USD Million)
Table 74 Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 75 Nuclear Medicine Equipment for Hospitals Offered by Major Players
Table 76 Nuclear Medicine Equipment Market for Hospitals, by Region, 2023-2030 (USD Million)
Table 77 Nuclear Medicine Equipment for Diagnostic Imaging Centers Offered by Major Players
Table 78 Nuclear Medicine Equipment Market for Diagnostic Imaging Centers, by Region, 2023-2030 (USD Million)
Table 79 Nuclear Medicine Equipment for Cancer Treatment Centers Offered by Major Players
Table 80 Nuclear Medicine Equipment Market for Cancer Treatment Centers, by Region, 2023-2030 (USD Million)
Table 81 Nuclear Medicine Equipment for Other End-Users Offered by Major Players
Table 82 Nuclear Medicine Equipment Market for Other End-Users, by Region, 2023-2030 (USD Million)
Table 83 Nuclear Medicine Equipment Market, by Region, 2023-2030 (USD Million)
Table 84 North America: Key Macroeconomic Indicators
Table 85 North America: Nuclear Medicine Equipment Market, by Country, 2023-2030 (USD Million)
Table 86 North America: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 87 North America: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 88 North America: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 89 North America: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 90 North America: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 91 North America: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 92 North America: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 93 North America: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 94 Us: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 95 Us: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 96 Us: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 97 Us: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 98 Us: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 99 Us: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 100 Us: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 101 Us: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 102 Canada: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 103 Canada: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 104 Canada: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 105 Canada: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 106 Canada: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 107 Canada: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 108 Canada: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 109 Canada: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 110 Europe: Key Macroeconomic Indicators
Table 111 Europe: Nuclear Medicine Equipment Market, by Country, 2023-2030 (USD Million)
Table 112 Europe: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 113 Europe: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 114 Europe: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 115 Europe: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 116 Europe: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type 2023-2030 (USD Million)
Table 117 Europe: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 118 Europe: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 119 Europe: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 120 Germany: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 121 Germany: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 122 Germany: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 123 Germany: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 124 Germany: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 125 Germany: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 126 Germany: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 127 Germany: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 128 Uk: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 129 Uk: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 130 Uk: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 131 Uk: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 132 Uk: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 133 Uk: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 134 Uk: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 135 Uk: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 136 France: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 137 France: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 138 France: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 139 France: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 140 France: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 141 France: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 142 France: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 143 France: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 144 Italy: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 145 Italy: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 146 Italy: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 147 Italy: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 148 Italy: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 149 Italy: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 150 Italy: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 151 Italy: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 152 Spain: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 153 Spain: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 154 Spain: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 155 Spain: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 156 Spain: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 157 Spain: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 158 Spain: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 159 Spain: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 160 Sweden: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 161 Sweden: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 162 Sweden: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 163 Sweden: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 164 Sweden: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 165 Sweden: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 166 Sweden: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 167 Sweden: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 168 Rest of Europe: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 169 Rest of Europe: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 170 Rest of Europe: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 171 Rest of Europe: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 172 Rest of Europe: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 173 Rest of Europe: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 174 Rest of Europe: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 175 Rest of Europe: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 176 Asia-Pacific: Key Macroeconomic Indicators
Table 177 Asia-Pacific: Nuclear Medicine Equipment Market, by Country, 2023-2030 (USD Million)
Table 178 Asia-Pacific: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 179 Asia-Pacific: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 180 Asia-Pacific: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 181 Asia-Pacific: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 182 Asia-Pacific: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 183 Asia-Pacific: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 184 Asia-Pacific: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 185 Asia-Pacific: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 186 Japan: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 187 Japan: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 188 Japan: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 189 Japan: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 190 Japan: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 191 Japan: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 192 Japan: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 193 Japan: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 194 China: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 195 China: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 196 China: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 197 China: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 198 China: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 199 China: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 200 China: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 201 China: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 202 India: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 203 India: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 204 India: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 205 India: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 206 India: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 207 India: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 208 India: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 209 India: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 210 South Korea: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 211 South Korea: Nuclear Medicine Equipment Market for Imaging Modalities, by Type 2023-2030 (USD Million)
Table 212 South Korea: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 213 South Korea: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 214 South Korea: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 215 South Korea: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 216 South Korea: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 217 South Korea: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 218 Australia: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 219 Australia: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 220 Australia: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 221 Australia: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 222 Australia: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 223 Australia: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 224 Australia: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 225 Australia: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)
Table 226 Rest of Asia-Pacific: Nuclear Medicine Equipment Market, by System Type, 2023-2030 (USD Million)
Table 227 Rest of Asia-Pacific: Nuclear Medicine Equipment Market for Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 228 Rest of Asia-Pacific: Nuclear Medicine Equipment Market for Spect, by Type, 2023-2030 (USD Million)
Table 229 Rest of Asia-Pacific: Nuclear Medicine Equipment Market for Pet, by Type, 2023-2030 (USD Million)
Table 230 Rest of Asia-Pacific: Nuclear Medicine Equipment Market for Non-Imaging Modalities, by Type, 2023-2030 (USD Million)
Table 231 Rest of Asia-Pacific: Nuclear Medicine Equipment Market, by Therapeutic Area, 2023-2030 (USD Million)
Table 232 Rest of Asia-Pacific: Nuclear Medicine Equipment Market, by Dimension, 2023-2030 (USD Million)
Table 233 Rest of Asia-Pacific: Nuclear Medicine Equipment Market, by End-User, 2023-2030 (USD Million)

Figure 1 Nuclear Medicine Equipment Market Segmentation and Regional Scope
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 CAGR Projections from Analysis of Market Dynamics
Figure 8 CAGR Projections: Supply-Side Analysis
Figure 9 Data Triangulation Methodology
Figure 10 Nuclear Medicine Equipment Market, by System Type, 2025 Vs. 2030 (USD Million)
Figure 11 Nuclear Medicine Equipment Market, by Dimension, 2025 Vs. 2030 (USD Million)
Figure 12 Nuclear Medicine Equipment Market, by Therapeutic Area, 2025 Vs. 2030 (USD Million)
Figure 13 Nuclear Medicine Equipment Market, by End-User, 2025 Vs. 2030 (USD Million)
Figure 14 Nuclear Medicine Equipment Market: Regional Snapshot
Figure 15 Growing Adoption of Advanced Imaging Modalities and Expansion of Theranostics to Drive Market
Figure 16 Oncology Segment and Japan Led Asia-Pacific Market in 2024
Figure 17 India to Grow at Highest CAGR During Forecast Period
Figure 18 Asia-Pacific to Dominate Market During Forecast Period
Figure 19 Emerging Markets to Register Higher Growth During Forecast Period
Figure 20 Nuclear Medicine Equipment Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Revenue Shift and New Revenue Pockets in Nuclear Medicine Equipment Market
Figure 22 Average Selling Price of Nuclear Cardiology Reporting Software, 2024 (USD)
Figure 23 Nuclear Medicine Equipment Market: Value Chain Analysis
Figure 24 Nuclear Medicine Equipment Market: Ecosystem Analysis
Figure 25 Investment and Funding Scenario, 2015-2025
Figure 26 Nuclear Medicine Equipment Market: Patent Analysis, 2015-2025
Figure 27 Nuclear Medicine Equipment Market: Porter's Five Forces Analysis
Figure 28 Influence of Stakeholders on Buying Process, by End-User
Figure 29 Key Buying Criteria for End-Users
Figure 30 Market Potential of Ai/Gen Ai on Nuclear Medicine Equipment Across Industries
Figure 31 Impact of Ai/Gen Ai on Interconnected and Adjacent Ecosystems
Figure 32 North America: Nuclear Medicine Equipment Market Snapshot, 2024
Figure 33 Asia-Pacific: Nuclear Medicine Equipment Market Snapshot, 2024
Figure 34 Revenue Analysis of Key Players in Nuclear Medicine Equipment Market, 2020-2024
Figure 35 Nuclear Medicine Equipment Market Share Analysis of Key Players, 2024
Figure 36 Positron Emission Tomography (Pet) Equipment Market Share Analysis of Key Players, 2024
Figure 37 Single-Photon Emission Computed Tomography (Spect) Equipment Market Share Analysis of Key Players, 2024
Figure 38 Market Ranking Analysis of Key Players, 2024
Figure 39 Nuclear Medicine Equipment Market: Brand/Product Comparison
Figure 40 Ev/Ebitda of Key Vendors
Figure 41 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta
Figure 42 Nuclear Medicine Equipment Market: Company Evaluation Matrix (Key Players), 2024
Figure 43 Nuclear Medicine Equipment Market: Company Footprint
Figure 44 Nuclear Medicine Equipment Market: Company Evaluation Matrix (Startups/Smes), 2024
Figure 45 Ge Healthcare: Company Snapshot (2024)
Figure 46 Siemens Healthineers Ag: Company Snapshot (2024)
Figure 47 Koninklijke Philips N.V.: Company Snapshot (2024)
Figure 48 Mirion Technologies, Inc.: Company Snapshot (2024)
Figure 49 Canon Medical Systems Corporation: Company Snapshot (2024)
Figure 50 Neusoft Medical Systems Co. Ltd.: Company Snapshot (2024)